Streetbeat News

Analyst Ratings

ANVS

Annovis Bio has announced an interim independent analysis for statistical power in its Alzheimer's study. The analysis is expected to provide insights into the effectiveness of the company's ongoing research.

Portfolio Pulse from Bill Haddad

October 12, 2023 | 12:06 pm

COUR

BMO Capital analyst Jeffrey Silber has initiated coverage on Coursera (NYSE:COUR) with an Outperform rating and a price target of $24.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 12:01 pm

JKHY

In the last quarter, Jack Henry & Associates (NASDAQ:JKHY) received mixed analyst ratings, with 4 bullish, 1 somewhat bullish, 6 indifferent, and 1 bearish. The average 12-month price target for the company is $173.33, a decrease of 3.5% from the previous average of $179.62.

Portfolio Pulse from Benzinga Insights

October 12, 2023 | 12:00 pm

NDAQ

Over the past 3 months, 4 analysts have published their opinion on Nasdaq (NASDAQ:NDAQ) stock. The company has an average price target of $68.25, which has increased by 24.09% from the previous average price target of $55.00. Two analysts have given bullish ratings, while two have remained indifferent.

Portfolio Pulse from Benzinga Insights

October 12, 2023 | 12:00 pm

CDAY

Ceridian HCM Holding (NYSE:CDAY) has received 2 bullish and 3 indifferent analyst ratings in the last quarter. The average 12-month price target for the company, according to 5 analysts, is $77.2, with a high of $84.00 and a low of $73.00. This average price target has increased by 6.73% over the past month.

Portfolio Pulse from Benzinga Insights

October 12, 2023 | 12:00 pm

TGT

In the last quarter, Target (NYSE:TGT) has received a mix of bullish and indifferent ratings from 33 analysts. The average price target is $149.45, which is higher than the current price of $112.37. However, this average has decreased by 7.36% from the previous average price target of $161.33.

Portfolio Pulse from Benzinga Insights

October 12, 2023 | 12:00 pm

MTZ

Over the past three months, seven analysts have published their opinions on MasTec (NYSE:MTZ) stock, with six giving bullish or somewhat bullish ratings and one being indifferent. The average 12-month price target for the company is $115.0, representing an 8.59% decrease from the previous average price target of $125.80.

Portfolio Pulse from Benzinga Insights

October 12, 2023 | 12:00 pm

SMAR

Over the last quarter, Smartsheet (NYSE:SMAR) has received 12 analyst ratings, with 5 being bullish, 4 somewhat bullish, and 3 indifferent. The company's average 12-month price target is $53.25, up 3.82% from the previous average of $51.29. No bearish ratings were observed.

Portfolio Pulse from Benzinga Insights

October 12, 2023 | 12:00 pm

IFF

Redburn Atlantic analyst Artem Chubarov has initiated coverage on Intl Flavors & Fragrances (IFF) with a Neutral rating and a price target of $60.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 11:59 am

RMD

RBC Capital analyst Craig Wong-Pan has downgraded ResMed (NYSE:RMD) from Outperform to Sector Perform and lowered the price target from $273 to $202.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 11:55 am